Cholangiocarcinoma primary prevention

Jump to navigation Jump to search

Cholangiocarcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangiocarcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangiocarcinoma primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangiocarcinoma primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangiocarcinoma primary prevention

CDC on Cholangiocarcinoma primary prevention

Cholangiocarcinoma primary prevention in the news

Blogs on Cholangiocarcinoma primary prevention

Directions to Hospitals Treating Cholangiocarcinoma

Risk calculators and risk factors for Cholangiocarcinoma primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] [3]

Overview

Effective measures for the primary prevention of cholangiocarcinoma hepatitis B vaccination, weight reduction, avoiding excess alcohol use.

Prevention

  • Effective measures for the primary prevention of cholangiocarcinoma include:[1][2]
    • Hepatitis B vaccination
    • Avoiding excess alcohol use
    • Weight reduction
    • Reducing the consumption of uncooked fish

References

  1. Patel T (2011). "Cholangiocarcinoma--controversies and challenges". Nat Rev Gastroenterol Hepatol. 8 (4): 189–200. doi:10.1038/nrgastro.2011.20. PMC 3888819. PMID 21460876.
  2. Braconi C, Patel T (2010). "Cholangiocarcinoma: new insights into disease pathogenesis and biology". Infect. Dis. Clin. North Am. 24 (4): 871–84, vii. doi:10.1016/j.idc.2010.07.006. PMC 2954129. PMID 20937455.

Template:WH Template:WS